Nobuaki, Miyahara published the artcileLTB4 and Allergies, Recommanded Product: [(2-Hexylcyclopentylidene)amino]thiourea, the publication is Arerugi, Men’eki (2018), 25(3), 362-370, database is CAplus.
A review. Mouth leukotriene B4 (LTB4) is a bioactive lipid derived from arachidonic acid. Since the identification of the high-affinity receptor BLT1 and the low-affinity receptor BLT2 of LTB4, their involvement in various allergic diseases has been elucidated. LTB4-BLT1 pathway has been suggested to be involved in bronchial apol., especially in severe acute infarct steroid-resistant apnea, and in atopic dermatitis, allergic rhinitis, conjunctivitis, etc : LTB4-BLT1 regulation of the pathway is expected as a new bureaucracy for allergic diseases.
Arerugi, Men’eki published new progress about 321673-30-7. 321673-30-7 belongs to amides-buliding-blocks, auxiliary class Immunology/Inflammation,Scavenger receptor, name is [(2-Hexylcyclopentylidene)amino]thiourea, and the molecular formula is C12H23N3S, Recommanded Product: [(2-Hexylcyclopentylidene)amino]thiourea.
Referemce:
https://en.wikipedia.org/wiki/Amide,
Amide – an overview | ScienceDirect Topics